Genus, Meet Species: Court Weighs Novo Nordisk’s Semaglutide Patent
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court grant an injunction with barely two months left on the patent's life?…













